GCM
PFE icon

Gladius Capital Management’s Pfizer PFE Stock Holding History

Gladius Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-73,600
Closed -$2.06M – 340
2024
Q2 		$2.06M Buy
73,600
+63,800
+651% +$1.76M 0.25% 45
2024
Q1 		$272K Buy
9,800
+6,400
+188% +$178K 0.09% 121
2023
Q4 		$97.9K Sell
3,400
-171,600
-98% -$5.19M 0.02% 152
2023
Q3 		$5.8M Buy
175,000
+93,400
+114% +$3.3M 0.24% 75
2023
Q2 		$2.99M Sell
81,600
-95,800
-54% -$3.73M 0.15% 66
2023
Q1 		$7.24M Buy
177,400
+147,500
+493% +$6.37M 0.42% 47
2022
Q4 		$1.53M Sell
29,900
-51,600
-63% -$2.47M 0.11% 53
2022
Q3 		$3.57M Buy
+81,500
New +$3.96M 0.16% 57
2022
Q2 		– Sell
-67,000
Closed -$3.47M – 403
2022
Q1 		$3.47M Sell
67,000
-11,600
-15% -$602K 0.26% 41
2021
Q4 		$4.64M Buy
78,600
+64,300
+450% +$3.19M 0.37% 41
2021
Q3 		$616K Hold
14,300
– – 0.04% 69
2021
Q2 		$560K Sell
14,300
-47,000
-77% -$1.83M 0.05% 78
2021
Q1 		$2.22M Sell
61,300
-147,600
-71% -$5.24M 0.08% 120
2020
Q4 		$7.69M Buy
208,900
+148,822
+248% +$5.46M 0.38% 77
2020
Q3 		$2.09M Buy
+60,078
New +$2.11M 0.21% 64
2020
Q1 		– Sell
-79,682
Closed -$2.96M – 172
2019
Q4 		$2.96M Sell
79,682
-64,716
-45% -$2.31M 0.19% 82
2019
Q3 		$4.92M Buy
144,398
+64,716
+81% +$2.35M 0.22% 83
2019
Q2 		$3.31M Sell
79,682
-333,908
-81% -$13.3M 0.2% 54
2019
Q1 		$16.7M Sell
413,590
-24,979
-6% -$1M 0.92% 22
2018
Q4 		$18.2M Buy
438,569
+380,599
+657% +$15.8M 0.89% 19
2018
Q3 		$2.42M Sell
57,970
-2,740
-5% -$105K 0.23% 16
2018
Q2 		$2.09K Buy
+60,710
New +$2.07M 0.21% 28

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gladius Capital Management's PFE Position: Q4 2024 in Review

Gladius Capital Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 1,043 shares — an estimated $30.2K sold.

Gladius Capital Management first reported a position in PFE in Q2 2018 and held it in 22 quarters. The position peaked at $7.34M in Q4 2018. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Gladius Capital Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 1,043 Pfizer shares in Q4 2024, an estimated $30.2K.
  • Gladius Capital Management first reported a position in Pfizer in Q2 2018 and held it in 22 quarters.
  • Gladius Capital Management's Pfizer position peaked at $7.34M in Q4 2018.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.